Edition:
United States

Changchun High & New Technology Industries Group Inc (000661.SZ)

000661.SZ on Shenzhen Stock Exchange

118.92CNY
9:28pm EST
Change (% chg)

¥-1.56 (-1.29%)
Prev Close
¥120.48
Open
¥120.00
Day's High
¥120.45
Day's Low
¥118.20
Volume
701,022
Avg. Vol
2,246,909
52-wk High
¥123.50
52-wk Low
¥77.13

Latest Key Developments (Source: Significant Developments)

Changchun High & New Technology Industries (Group) announces outcome of rights issue offering
Tuesday, 26 Apr 2016 08:00pm EDT 

Changchun High & New Technology Industries (Group) Inc:Issues 38,785,695 shares of common stock with par value of 1 yuan per share, at the price of 45.68 yuan per share to its existing shareholders and raised 1,771,730,547.60 yuan in total.Shareholders are eligible to purchase three new shares for every 10 shares they hold.  Full Article

Changchun High & New Technology Industries (Group) to offer rights issue
Monday, 18 Apr 2016 08:00pm EDT 

Changchun High & New Technology Industries (Group) Inc:To issue 39,397,971 shares of common stock with par value of 1 yuan per share, at the price of 45.68 yuan per share to its existing shareholders.Shareholders are eligible to purchase three new shares for every 10 shares they hold.The company aims to raise up to 1.8 billion yuan through the rights issue.Zhong De Securities will be the leading underwriter of the rights issue.  Full Article

Changchun High & New Technology Industries (Group) offers rights issue
Wednesday, 13 Apr 2016 08:00pm EDT 

Changchun High & New Technology Industries (Group) Inc:To issue 39,397,971 shares of common stock with par value of 1 yuan per share, at the price of 45.68 yuan per share to its existing shareholders.Shareholders are eligible to purchase three new shares for every 10 shares they hold.The company aims to raise up to 1,800 million yuan through the rights issue.Zhong De Securities Co., Ltd. will be the leading underwriter of the rights issue.  Full Article

Changchun High & New Technology Industries issues 2016 Q1 net profit outlook
Wednesday, 6 Apr 2016 08:00pm EDT 

Changchun High & New Technology Industries (Group) Inc:Sees net profit for 2016 Q1 to increase by 21.64 percent to 32.04 percent, or to be 117,000,000 yuan to 127,000,000 yuan.Says the net profit of 2015 Q1 was 96,184,600 yuan.Comments that increased income from pharmaceutical units and real estate units is the main reason for the forecast.  Full Article

Changchun High & New Technology Industries (Group) announces 2015 dividend payment date
Tuesday, 5 Apr 2016 08:00pm EDT 

Changchun High & New Technology Industries (Group) Inc:To pay cash dividend of 8 yuan per 10 shares (before tax) to shareholders of record on April 11 for 2015.The company's shares will be traded ex-right and ex-dividend on April 12 and the dividend will be paid on April 12.  Full Article

Changchun High & New Technology Industries (Group) subsidiary to acquire stake in Changchun-based company
Thursday, 10 Mar 2016 07:00pm EST 

Changchun High & New Technology Industries (Group) Inc:Says wholly owned Changchun-based real estate development subsidiary to acquire 24 pct stake in a Changchun-based real estate development company from another Changchun-based real estate development company for 4.8 mln yuan.  Full Article

Changchun High & New Technology Industries (Group) announces 2015 dividend payment
Thursday, 10 Mar 2016 07:00pm EST 

Changchun High & New Technology Industries (Group) Inc:To pay cash dividend of 8 yuan per 10 shares (before tax) to shareholders for 2015.  Full Article

Changchun High & New Technology Industries (Group) unit passes GMP recognition
Tuesday, 23 Feb 2016 07:00pm EST 

Changchun High & New Technology Industries (Group) Inc:Says its Changchun-based unit received goods manufacture practice (GMP) certificate from China Food and Drug Administration on Feb. 23.Certificate issued to Triptorelin Acetate manufactured by the unit and the valid period is until Feb. 15, 2021.  Full Article

Changchun High & New Technology Industries (Group) subsidiary receives approval for clinical trial
Monday, 15 Feb 2016 07:00pm EST 

Changchun High & New Technology Industries (Group) Inc:Says changchun-based subsidiary received approval from China Food and Drug Administration on Feb. 15, for clinical trial for recombinant human growth hormone injection.  Full Article

Changchun High & New Technology Industries (Group) subsidiary wins bid
Thursday, 29 Oct 2015 08:00pm EDT 

Changchun High & New Technology Industries (Group) Inc:Says wholly owned Changchun-based real estate development subsidiary won bid to undertake urban renewal project in Changchun.Bid price 12,047.82 mln yuan.  Full Article